Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/28/2007EP1859795A1 Therapeutic agent for ophthalmic disease
11/28/2007EP1859794A1 Sustained release supplements
11/28/2007EP1859793A1 Novel combinational use of sulfonamide compound
11/28/2007EP1859790A2 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
11/28/2007EP1859789A1 Dosage form that is secured against misuse
11/28/2007EP1859786A1 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
11/28/2007EP1859774A1 Hair cosmetic
11/28/2007EP1859679A1 Protective solution for preventing ischaemia damage
11/28/2007EP1859274A2 Genes involved in neurodegenerative conditions
11/28/2007EP1859040A2 Compositions and their uses directed to il-4r alpha
11/28/2007EP1858930A1 Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars
11/28/2007EP1858910A2 Novel betulinic acid derivatives a-ring-condensed to a heterocyclic group
11/28/2007EP1858902A1 Bicyclic heteroaromatic derivatives useful as anticancer agents
11/28/2007EP1858901A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/28/2007EP1858900A1 Fused thiazole derivatives having affinity for the histamine h3 receptor
11/28/2007EP1858898A1 Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use
11/28/2007EP1858896A1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists
11/28/2007EP1858895A2 Piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858893A1 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents
11/28/2007EP1858892A1 Anhydrous ziprasidone mesylate and a process for its preparation
11/28/2007EP1858891A2 Crystalline forms of ziprasidone mesylate
11/28/2007EP1858890A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
11/28/2007EP1858889A1 Bicyclic nucleosides and nucleotides as therapeutic agents
11/28/2007EP1858888A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858887A1 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
11/28/2007EP1858886A1 Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
11/28/2007EP1858885A1 Indolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858884A1 Indazolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858883A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/28/2007EP1858882A1 Pyrimidine derivatives for treatment of hyperproliferative disorders
11/28/2007EP1858881A1 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
11/28/2007EP1858880A1 Amido-substituted 6-phenylphenanthridines
11/28/2007EP1858879A1 1,3-diaryl substituted ureas as modulators of kinase activity
11/28/2007EP1858877A1 1,3 substituted diaryl ureas as modulators of kinase activity
11/28/2007EP1858876A2 Pyridinone derivatives against malaria
11/28/2007EP1858875A2 Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neurotransmission
11/28/2007EP1858874A1 (s)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine-di-p-toluoyl-l-tartarate and methods of preparation thereof
11/28/2007EP1858873A2 Process for the purification of duloxetine hydrochloride
11/28/2007EP1858872A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists
11/28/2007EP1858870A1 Semi-synthetic taxane derivatives with antitumor activity
11/28/2007EP1858869A1 Acylated piperidines as glycine transporter inhibitors
11/28/2007EP1858868A1 Compounds
11/28/2007EP1858867A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof
11/28/2007EP1858865A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
11/28/2007EP1858864A2 Stabilized compositions of volatile alkylating agents and methods of using thereof
11/28/2007EP1858863A1 Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of use
11/28/2007EP1858862A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS
11/28/2007EP1858861A1 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
11/28/2007EP1858860A1 Phthalazinones
11/28/2007EP1858859A1 Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
11/28/2007EP1858857A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
11/28/2007EP1858856A2 Cancer treatment using specific 3,6,9-substituted acridines
11/28/2007EP1858854A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists
11/28/2007EP1858853A2 Novel pyridine derivatives as potassium ion channel openers
11/28/2007EP1858852A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists
11/28/2007EP1858849A1 Organic compounds
11/28/2007EP1858847A1 Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions
11/28/2007EP1858845A2 Novel tyrosine derivatives
11/28/2007EP1858836A1 Analogues of the azinomycins as anti-tumour agents and as prodrugs
11/28/2007EP1858592A2 Treatment of inflammatory bowel disease
11/28/2007EP1858556A1 Vehicle for topical delivery of anti-inflammatory compounds
11/28/2007EP1858554A2 New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
11/28/2007EP1858552A2 Composition comprising human igg2 antibody and a chelating agent
11/28/2007EP1858539A2 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
11/28/2007EP1858530A2 Immunostimulating polyphosphazene compounds
11/28/2007EP1858529A2 Blood soluble drag reducing hyaluronic acid
11/28/2007EP1858528A2 Process for crystallizing lactose particles for use in pharmaceutical formulations
11/28/2007EP1858527A1 Oral dosage forms of gemcitabine derivatives
11/28/2007EP1858526A1 Glycoalkaloid and tlr agonist combinations and various uses thereof
11/28/2007EP1858525A2 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use
11/28/2007EP1858524A2 Compositions and methods for treatment of autoimmune and related diseases
11/28/2007EP1858523A1 Combinaion therapy for topical application in the treatment of dry eye syndrome
11/28/2007EP1858522A1 Pharmaceutically acceptable carrier for ophthalmic compositions
11/28/2007EP1858521A2 Compounds and compositions as protein kinase inhbitors
11/28/2007EP1858520A2 Quinazolinone t-type calcium channel antagonists
11/28/2007EP1858519A2 Orally used compatible solute containing agents
11/28/2007EP1858517A2 Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
11/28/2007EP1858515A2 Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
11/28/2007EP1858514A1 Pharmaceutical tablets of crystalline type ii aripiprazole
11/28/2007EP1858513A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
11/28/2007EP1858512A2 Methods of treating cancer using ppar-gamma antagonists
11/28/2007EP1858511A1 Pharmaceutical compositions comprising sirolimus and/or an analogue thereof
11/28/2007EP1858510A1 Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound
11/28/2007EP1858509A1 Novel cathepsin c inhibitors and their use
11/28/2007EP1858508A1 Compounds having anti-cancer properties
11/28/2007EP1858507A2 Polyphenol coxib combinations and methods
11/28/2007EP1858506A2 Methods of treating ear infections
11/28/2007EP1858505A2 Polyacetylen compounds isolated from cussonia
11/28/2007EP1858504A1 Carnitine-containing peritoneal dialysis solution having improved biocompatibility
11/28/2007EP1858503A1 Topical gels compositions
11/28/2007EP1858502A1 Methods and pharmaceutical compositions for the treatment of neurological damage
11/28/2007EP1858501A1 Nmda receptor antagonists in the medical intervention of metabolic disorders
11/28/2007EP1858500A2 Medicinal compositions of salts, chelates and/or free acids of alpha hydroxyl organic acids and related processes and methods
11/28/2007EP1858499A1 Methods for treatment of retinal degenerative disease
11/28/2007EP1858498A2 Use of microtubule stabilizing compounds for the treatment of lesions of cns axons
11/28/2007EP1858497A2 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
11/28/2007EP1858496A1 Transdermal therapeutic system for the administration of analgesics
11/28/2007EP1858495A2 Device for delivery of trpv1 agonists
11/28/2007EP1858491A1 Sublingual coated tablet
11/28/2007EP1858490A1 Pharmaceutical forms with improved pharmacokinetic properties
1 ... 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 ... 7860